LabCorp says U.S. FDA granted emergency use authorization for the Pixel by LabCorp™ covid-19 test home collection kit.
- Collection kit to become the first over the counter product in the U.S.
- Approval will enable LabCorp to potentially distribute the kit through retail channels
To view the source of this information click
To contact the reporter on this story:
To contact the editor responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.